Jim Simons's position in Ventyx Biosciences is currently worth $235 Thousand. That's 0.00% of their equity portfolio (3197th largest holding). The stake costed the investor $158 Thousand, netting the investor a gain of 49% so far.
Avg closing price
Price range
Increased shares by 17.2% (+1 Thousand shares)
Q4 2022